Dr. Tania Maria Caballero is a pediatrician and clinician scientist committed to improving contraceptive access for uninsured immigrant mothers through innovative solutions in pediatric primary care. Dr. Caballero completed her general pediatrics residency at University of Rochester, NY and a Master of Health Science (MHS) from Johns Hopkins School of Public Health. Over the past ...Read more >

Adrienne Ghorashi, JD is a Program Manager at the Center for Public Health Law Research at Temple University’s Beasley School of Law. Ms. Ghorashi is passionate about building multidisciplinary, open access, and community-engaged research that examines the role of laws and policies in creating or mitigating structural barriers to equitable abortion access through a Reproductive ...Read more >

Jennifer James is an Assistant Professor in the Institute for Health and Aging, the Department of Social and Behavioral Sciences, and the Bioethics program at the University of California, San Francisco (UCSF). Dr. James is a qualitative researcher and Black Feminist scholar whose research lies at the intersection of race, gender and health, with a ...Read more >

The COVID-19 pandemic triggered the rapid implementation of innovations to reduce contact between patients and providers, including providing medication abortions without prior clinical exams or ultrasounds. The No-Test Medication Abortion (NTMA) study team expeditiously formed a cohesive working group and created infrastructure to collect data on patients receiving this model of care. Similarly other service ...Read more >

We request this Society of Family Planning research funding to address two of SFPRF’s priorities in generating evidence for novel abortion services: (1) to what extent does medication abortion with telemedicine shift abortion access for specific US patient populations and geographies? and (2) what are best practices in patient-provider communications related to improving telemedicine service ...Read more >

The requirement of ultrasound to determine gestational age prior to medication abortion remains a common practice and creates an access issue. Early in the COVID-19 pandemic, we began providing medication abortion without an ultrasound to patients with a reasonably sure last menstrual period (LMP) and a low risk for ectopic pregnancy. From our experience and ...Read more >

COVID-19 prompted healthcare organizations to innovate and adopt novel models for delivering abortion to their patients safely and with minimal contact. This project studies patients’ experiences of COVID-19-related telemedicine abortion, including mifepristone delivery, and examines the extent to which telemedicine shifted abortion access for patients served by the Cambridge Health Alliance (CHA) primary care network ...Read more >

In Spring 2020 amidst the onset of the COVID-19 pandemic, UCLA Health implemented a no-test telemedicine abortion (NTTA) model of care, wherein women could access a medication abortion without an ultrasound or in-person clinic visit. Utilizing the strengths of our multi-disciplinary team, the proposed mixed-methods project seeks to examine potential differences between NTTA and clinic-based ...Read more >

Early pregnancy loss (EPL) is defined as a nonviable, intrauterine pregnancy prior to 13 weeks of gestation. In the United States, there are about 1 million EPLs per year. In the ED setting, treating EPL can be challenging. ED physicians normally recommend Obstetrics and Gynecology (Ob/Gyn) outpatient or inpatient consult often leading to a delay ...Read more >

Little is known about patients’ experiences of grief after abortion for fetal indications or pregnancy complications in the second trimester. The typical grief response is a process of expected distress during the acute grief period with a transition to integrated grief marked by the development of healthy coping skills and acceptance of the loss. While ...Read more >